Dear Sir/Madam, Please find the attached confirmation regarding non-applicability of large corporate entity framework. You are requested to take the same on record and oblige. Thanks ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Prism Medico and Pharmacy Ltd has informed BSE and MSEI that it does not qualify as a 'large corporate entity' under SEBI's framework (SEBI/HO/DDHS/CIR/P/2018/144 dated 26 December 2018) as of 31 March 2026. The large corporate framework applies to listed entities with outstanding borrowings exceeding ₹100 crore, imposing additional fund-raising and disclosure obligations. Since the company falls outside this criteria, it is exempt from filing the additional disclosures required under this framework. The letter is signed by Sameer Gupta (Company Secretary) and Bharat Singh (CFO).
This is a routine compliance confirmation and has no material impact on the stock price or shareholders. It simply clarifies that the company is not subject to the stricter borrowing and disclosure rules that apply to larger listed entities, suggesting its outstanding borrowings are below the ₹100 crore threshold.